Literature DB >> 25843818

Knowledge, practices, and opinions of ontario dentists when treating patients receiving bisphosphonates.

Ahmed Alhussain1, Sean Peel2, Laura Dempster2, Cameron Clokie3, Amir Azarpazhooh4.   

Abstract

PURPOSE: Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is a severe but extremely rare complication of prolonged treatment with bisphosphonates (BPs). Improper treatment or misdiagnosis can have serious repercussions. In some cases, the treatment of BRONJ can require jaw resection, prolonged use of antibiotics, and long hospitalizations. This study aimed to measure the awareness of dentists in the Province of Ontario, Canada about BRONJ and to identify any gaps in their knowledge of the condition and its treatment. In particular, the study aimed to answer questions about the dentists' knowledge of the current guidelines and their opinions and practices related to performing surgical dental procedures in patients taking BPs.
MATERIALS AND METHODS: The study involved sending a Web-based questionnaire to a random sample of dentists in Ontario, Canada (n = 1,579). Information about their awareness of BPs, their experiences treating patients presenting with ONJ, their experiences with different surgical procedures in patients taking intravenous or oral BPs, and their awareness of the BRONJ guidelines suggested by the American Association of Oral and Maxillofacial Surgeons was collected.
RESULTS: A response rate of 30% was achieved. Sixty percent of responding dentists had a good knowledge of BP and BRONJ; however, only 23% followed the guidelines for surgical treatment of a patient taking BPs, and 63% would refer patients if they were taking BPs. Approximately 50% of responding Ontario dentists were not comfortable treating patients with BRONJ at their current knowledge.
CONCLUSION: The finding shows that although 60% of Ontario general dentists and specialists have a good knowledge about BRONJ, most are not comfortable performing oral surgery in patients taking BPs. Those who are comfortable have higher knowledge scores, suggesting greater educational efforts should be made to promote the knowledge of dentists regarding BP, ONJ, and BRONJ.
Copyright © 2015 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25843818     DOI: 10.1016/j.joms.2014.12.040

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  15 in total

1.  Dentists' knowledge about medication-related osteonecrosis of the jaw and its management.

Authors:  R Al-Eid; T Alduwayan; M Bin Khuthaylah; M Al Shemali
Journal:  Heliyon       Date:  2020-07-27

2.  Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals.

Authors:  Wanessa Miranda-Silva; Marco Aurélio Montezuma; Bernar Monteiro Benites; Julia Stephanie Bruno; Felipe Paiva Fonseca; Eduardo Rodrigues Fregnani
Journal:  Support Care Cancer       Date:  2020-03-06       Impact factor: 3.603

3.  Choosing the Right Partner for Medication Related Osteonecrosis of the Jaw: What Central European Dentists Know.

Authors:  Emanuel Bruckmoser; Miriam Palaoro; Lukas Latzko; Dagmar Schnabl; Sabrina B Neururer; Johannes Laimer
Journal:  Int J Environ Res Public Health       Date:  2021-04-22       Impact factor: 3.390

4.  Viewpoints of dentists on the use of bisphosphonates in rheumatology patients.

Authors:  Coline Daron; Christophe Deschaumes; Martin Soubrier; Sylvain Mathieu
Journal:  Int Dent J       Date:  2018-02-15       Impact factor: 2.607

5.  Medication-related osteonecrosis of the jaw: knowledge and perceptions of medical professionals on the usage of bone modifying agents and dental referrals.

Authors:  Shruthi Acharya; Vathsala Patil; Vineetha Ravindranath; Adarsh Kudva; Krithi Nikhil
Journal:  J Med Life       Date:  2022-03

6.  Knowledge of bisphosphonate-related osteonecrosis of the Jawsamong Mexican dentists.

Authors:  I Vinitzky-Brener; N-G Ibáñez-Mancera; A-M Aguilar-Rojas; A-P Álvarez-Jardón
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-01-01

7.  Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition.

Authors:  Mario Migliario; Giovanni Mergoni; Paolo Vescovi; Iolanda De Martino; Manuela Alessio; Luca Benzi; Filippo Renò; Vittorio Fusco
Journal:  Dent J (Basel)       Date:  2017-03-16

8.  Knowledge and Opinions of Saudi Dentists Regarding Dental Treatment of Patients Undergoing Bisphosphonates.

Authors:  Sadeq Ali Al-Maweri; Maha Naif Alshammari; Abdulaziz Rabah Alharbi; Aisha Abdullah Bahein; Mohammed Nasser Alhajj; Hashem Motahir Al-Shamiri; Ahmed Wallan Alahmary; Mazen Doumani
Journal:  Eur J Dent       Date:  2020-02-07

9.  Dentists' knowledge about osteoporosis and their ability to identify the disease.

Authors:  Renato Vicente Ferreira; Suely Roizenblatt; Vera Lucia Szejnfeld
Journal:  Adv Rheumatol       Date:  2021-08-09

10.  Influence of the teaching program on the learning in knowledge and practice of osteonecrosis of the jaws produced by antireasorptives in dental students of the Principality of Asturias (Spain).

Authors:  Matias-Ferrán Escobedo; Luis García-Consuegra; Silvia Gay; Lorena Álvarez; Sonsoles Olay; Giuliano Ascani; Luis Junquera
Journal:  J Clin Exp Dent       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.